Vertex Ventures HC logo

Vertex Ventures HC

North America, California, United States, Palo Alto

Description

Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health.

Investor Profile

Vertex Ventures HC has made 40 investments, with 3 in the past 12 months and 8% as lead.

Stage Focus

  • Series B (33%)
  • Series C (25%)
  • Series A (25%)
  • Series D (10%)
  • Series E (3%)
  • Debt Financing (3%)
  • Series Unknown (3%)

Country Focus

  • United States (93%)
  • United Kingdom (3%)
  • Switzerland (3%)
  • China (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Life Science
  • Clinical Trials
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Vertex Ventures HC frequently co-invest with?

Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 9
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 5
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 8
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 5
Vertex Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 18
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 7
Windham Venture Partners
North America, New York, United States, New York
Co-Investments: 7
Aisling Capital
North America, New York, United States, New York
Co-Investments: 5
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 6

Which angels does Vertex Ventures HC often collaborate with?

Shared Deals: 1

What are some of recent deals done by Vertex Ventures HC?

Indapta Therapeutics

San Francisco, California, United States

Indapta Therapeutics is a privately held biotechnology company.

BiopharmaBiotechnologyMedical
Series UnknownDec 17, 2024
Amount Raised: $22,500,000
Moximed

Hayward, California, United States

Moximed develops innovative therapies for patients with knee osteoarthritis.

BiotechnologyHealth CareMedical Device
Series DAug 13, 2024
Amount Raised: $61,000,000
NeuSpera Medical

San Jose, California, United States

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Machinery ManufacturingMedical DeviceProduct Design
Series DJul 15, 2024
Amount Raised: $23,000,000
TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials
Series BApr 10, 2024
Amount Raised: $158,000,000
Eyebiotech

New York, New York, United States

Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.

BiotechnologyMedical
Series ANov 14, 2023
Amount Raised: $65,000,000
Septerna

San Francisco, California, United States

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

BiotechnologyInformation TechnologyMedicalSoftware
Series BJul 11, 2023
Amount Raised: $150,000,000
Spyglass Pharma

Aliso Viejo, California, United States

Spyglass Pharma provides medicine for ophthalmic diseases.

DeliveryMedicalPharmaceutical
Series CJul 10, 2023
Amount Raised: $90,000,000
Boundless Bio

La Jolla, California, United States

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Series CMay 16, 2023
Amount Raised: $100,000,000
TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials
Series BApr 13, 2023
Amount Raised: $158,000,000
SonoThera

San Francisco, California, United States

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.

BiopharmaBiotechnologyGeneticsMedical
Series ADec 5, 2022
Amount Raised: $60,750,000